Clinically meaningful changes on depressive symptom measures and patient‐reported outcomes in patients with treatment‐resistant depression

Measuring Clinical Importance in a Trial of Interventions for Mixed Urinary Incontinence

(2020) Toshi A. Furukawa   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Patient Health Questionnaire-9 scores do not accurately estimate depression prevalence: individual participant data meta-analysis

(2020) Brooke Levis et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

One (effect) size does not fit at all: Interpreting clinical significance and effect sizes in depression treatment trials

(2020) Fredrik Hieronymus et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study

(2019) Vanina Popova et al.   AMERICAN JOURNAL OF PSYCHIATRY

Efficacy and Safety of Fixed-Dose Esketamine Nasal Spray Combined With a New Oral Antidepressant in Treatment-Resistant Depression: Results of a Randomized, Double-Blind, Active-Controlled Study (TRANSFORM-1)

(2019) Maggie Fedgchin et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Improving Depression Outcome by Patient-Centered Medical Management

(2018) A. John Rush et al.   AMERICAN JOURNAL OF PSYCHIATRY

Distribution- and anchor-based methods to determine the minimally important difference on patient-reported outcome questionnaires in oncology: a structured review

(2018) Ahmad Ousmen et al.   Health and Quality of Life Outcomes

Determination of a clinically important difference and definition of a responder threshold for the UCSD performance-based skills assessment (UPSA) in patients with major depressive disorder

(2017) Philip D. Harvey et al.   JOURNAL OF AFFECTIVE DISORDERS

What does the MADRS mean? Equipercentile linking with the CGI using a company database of mirtazapine studies

(2017) Stefan Leucht et al.   JOURNAL OF AFFECTIVE DISORDERS

Evidence to Support Montgomery-Asberg Depression Rating Scale Administration Every 24 Hours to Assess Rapid Onset of Treatment Response

(2016) Kristen M. Johnson et al.   JOURNAL OF CLINICAL PSYCHIATRY

Isn’t It About Time to Employ Measurement-Based Care in Practice?

(2015) A. John Rush   AMERICAN JOURNAL OF PSYCHIATRY

Narrowing the Gaps Between What We Know and What We Do in Psychiatry

(2015) A. John Rush   JOURNAL OF CLINICAL PSYCHIATRY

Determining the clinical importance of treatment benefits for interventions for painful orthopedic conditions

(2015) Nathaniel P Katz et al.   Journal of Orthopaedic Surgery and Research

The structure of the Montgomery-Åsberg depression rating scale over the course of treatment for depression

(2013) Lena C. Quilty et al.   INTERNATIONAL JOURNAL OF METHODS IN PSYCHIATRIC RESEARCH

Relationship between the clinical global impression of severity for schizoaffective disorder scale and established mood scales for mania and depression

(2013) Ibrahim Turkoz et al.   JOURNAL OF AFFECTIVE DISORDERS

Evaluating and Monitoring Treatment Response in Depression Using Measurement-Based Assessment and Rating Scales

(2013) Madhukar H. Trivedi   JOURNAL OF CLINICAL PSYCHIATRY

Utility and limitations of PHQ-9 in a clinic specializing in psychiatric care

(2012) Takeshi Inoue et al.   BMC Psychiatry

Enhancing the clinical utility of depression screening

(2012) K. Kroenke   CANADIAN MEDICAL ASSOCIATION JOURNAL

Comparison of Distribution- and Anchor-Based Approaches to Infer Changes in Health-Related Quality of Life of Prostate Cancer Survivors

(2012) Ravishankar Jayadevappa et al.   HEALTH SERVICES RESEARCH

Assessing treatment effects in clinical trials with the Discan metric of the Sheehan Disability Scale

(2009) Kathy Harnett Sheehan et al.   INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY